Alpha 2.0
Login Register
» Authors » P N A Harris

P N A Harris

Explore the profile of P N A Harris including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 173
Followers 0
Related Specialties
Infectious Diseases
Pharmacology
Pathology
Top 10 Co-Authors
D L Paterson
J Lipman
D C Lye
K B Laupland
J F McNamara
J De Waele
B A Rogers
A Y Peleg
M D Chatfield
K J Denny
Published In
Clin Microbiol Infect
Int J Antimicrob Agents
Clin Infect Dis
Pathology
Antimicrob Agents Chemother
Affiliations
Soon will be listed here.
Recent Articles
1.
Molecular Epidemiology of Third-Generation-Cephalosporin-Resistant in Southeast Queensland, Australia
Stewart A, Price E, Schabacker K, Birikmen M, Harris P, Choong K, et al.
Antimicrob Agents Chemother . 2021 Mar; 65(6). PMID: 33781999
Third-generation cephalosporin-resistant (3GC-R) represent a major threat to human health. Here, we captured 288 3GC-R clinical isolates from 264 patients presenting at a regional Australian hospital over a 14-month period....
2.
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study
Henderson A, Paterson D, Chatfield M, Tambyah P, Lye D, De P, et al.
Clin Infect Dis . 2020 Oct; 73(11):e3842-e3850. PMID: 33106863
Introduction: This study aims to assess the association of piperacillin/tazobactam and meropenem minimum inhibitory concentration (MIC) and beta-lactam resistance genes with mortality in the MERINO trial. Methods: Blood culture isolates...
3.
Erratum to 'When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit' [Clin Microbiol Infect 26 (1) (January 2020) 35-40]
Denny K, De Waele J, Laupland K, Harris P, Lipman J
Clin Microbiol Infect . 2020 Jan; 26(6):801. PMID: 31968270
No abstract available.
4.
Measuring patient-centred long-term outcome following a bloodstream infection: a pilot study
McNamara J, Harris P, Chatfield M, Lorenc P, Paterson D
Clin Microbiol Infect . 2019 Oct; 26(2):257.e1-257.e4. PMID: 31654791
Objectives: To evaluate the sequential organ failure assessment (SOFA) and modified SOFA (mSOFA) scoring and a novel performance score based on the Karnofsky score for measuring outcome following a bloodstream...
5.
When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit
Denny K, De Waele J, Laupland K, Harris P, Lipman J
Clin Microbiol Infect . 2019 Jul; 26(1):35-40. PMID: 31306790
Background: Most intensive care unit (ICU) patients receive broad-spectrum antibiotics. While lifesaving in some, in others these treatments may be unnecessary and place patients at risk of antibiotic-associated harms. Objectives:...
6.
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition
Harris P, McNamara J, Lye D, Davis J, Bernard L, Cheng A, et al.
Clin Microbiol Infect . 2016 Nov; 23(8):533-541. PMID: 27810466
Objectives: To define standardized endpoints to aid the design of trials that compare antibiotic therapies for bloodstream infections (BSI). Methods: Prospective studies, randomized trials or registered protocols comparing antibiotic therapies...
7.
Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice?
Harris P, Alder L, Paterson D
Pathology . 2015 May; 47(4):386-8. PMID: 25938360
No abstract available.
8.
Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
Harris P, Ferguson J
Int J Antimicrob Agents . 2012 Jul; 40(4):297-305. PMID: 22824371
Some bacteria that possess chromosomally determined AmpC β-lactamases may express these enzymes at a high level following exposure to β-lactams, either by induction or selection for derepressed mutants. This may...